i think this one a little different..., page-24

Who is doing research on competing drugs?

If they are listed on he ASX...or on another exchange...what are their markets caps and what value does the market apply to the Melanoma drugs?

Are they majors...or minnows like VLA?

Or are they large, government funded bodies?

With a market cap of some $42m tonight, discounting their other potential assets, the queston we need to ask is...what value will the market put on the potential for a successful treatment for Melanoma?

If you can find a listed comparison, then whack a relative value on it and back it into VLA's market cap for a reference.

Herein lies the blue sky the market will push this to.

But...if you cannot find any listed entities with similar results, then it makes VLA look even more attractive.

Cheers!